Artiva Biotherapeutics Revenue and Competitors

Claim your profile

Location

#6247

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Artiva Biotherapeutics's estimated annual revenue is currently $7.1M per year.(i)
  • Artiva Biotherapeutics's estimated revenue per employee is $134,528
  • Artiva Biotherapeutics's total funding is $198M.

Employee Data

  • Artiva Biotherapeutics has 53 Employees.(i)
  • Artiva Biotherapeutics grew their employee count by 77% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$27.4M146-5%$160MN/A
#2
$3.7M24N/AN/AN/A
#3
$18.1M93-3%$24.1MN/A
#4
$47.1M304-3%N/AN/A
#5
$48.1M28014%$403MN/A
#6
$459.2M206854%$242.6MN/A
#7
$0.9M14133%$6.1MN/A
#8
$14.9M79-12%$140MN/A
#9
$29M187-1%N/AN/A
#10
$3.7M24N/AN/AN/A

At Artiva, our mission is to deliver to cancer patients highly effective cellular immunotherapies that are also safe and immediately accessible. Towards this end, Artiva is advancing a pipeline of off-the-shelf, allogeneic NK cell therapies, including CAR-NK cell therapies, that leverage the company’s unique manufacturing and engineering capabilities. Artiva is headquartered in San Diego.

keywords:N/A

$198M

Total Funding

53

Number of Employees

$7.1M

Revenue (est)

77%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Artiva Biotherapeutics News

2022-04-06 - Artiva Biotherapeutics Announces Agreement with Merck to ...

Artiva's platform supports large-scale production and cryopreservation of off-the-shelf allogeneic NK and CAR-NK therapeutics. About Artiva...

2022-04-06 - Rough biotech market won't stop 5AM Ventures' new $750M ...

... the firm invested in Artiva Biotherapeutics, a private developer of ... adding that 5AM primarily gravitates toward therapeutics...

2021-03-01 - Daily funding roundup - March 1st, 2021

Skydio raised $170M; Artiva landed $120M; FogPharma secured $107M; Axonius picks up $100M Skydio: Skydio is a Redwood City, Ca.-based autonomous drone-maker. Skydio has raised $170 million in Series D funding at a post-money valuation of more than $1 billion led by earlier investor Andreessen H ...

2021-03-01 - Artiva Biotherapeutics Finds $120M In Series B

San Diego-based biopharmaceuticals company Artiva Biotherapeutics has raised a big, $120M funding round, in its Series B funding, according to the company. The funding was led by Venrock Healthcare Capital Partners, and also included Acuta Capital Partners, Cormorant Asset Management, EcoR1 Capi ...

2021-02-26 - Artiva Biotherapeutics, Inc. announced that it has received $120.000001 million in funding from a group of investors

On February 26, 2021, Artiva Biotherapeutics, Inc. closed the transaction. The company raised funding led by by new investor Venrock Healthcare Capital Partners, a fund managed by Venrock. The transaction included participation from other new investors Acuta Capital Partners LLC, Cormorant Asset ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.8M53-4%N/A
#2
$12.1M5313%N/A
#3
$5.7M5356%N/A
#4
$11.9M53-17%N/A
#5
$6.9M5310%N/A